PF15

General Information


DRACP ID  DRACP05740

Peptide Name   PF15

Sequence  AGYLLGXLLOOLAAAALOOLL

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Stearylation

C-terminal Modification  Amidation

Other Modification  X=Lys(ε-Mtt), Trifluoromethylquinoline moietie is added at amino froup of Lys7

Chiral  L



Physicochemical Information


Formula  C76H120N16O13

Absent amino acids  CDEFHIKMNPQRSTVW

Common amino acids  L

Mass  193285

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  13

Net charge  0

Boman Index  5015

Hydrophobicity  177.62

Aliphatic Index  172.38

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  74.5

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23200958

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2850

DRACP is developed by Dr.Zheng's team.